Feature Assay: Sexually Transmitted Infections (STI)
Innovations in Molecular Diagnostics

Feature Assay: Sexually Transmitted Infections (STI)

How can your laboratory deliver more accurate and impactful results for the detection and treatment of sexually transmitted infections?

According to the World Health Organization, more than 1 million sexually transmitted infections (STIs) are acquired every day worldwide.1 STIs have a range of signs and symptoms including vaginal or urethral discharge, genital ulcers, and abdominal pain. As STIs can lead to serious health consequences such as cervical cancer, pelvic inflammatory disease (PID) and infertility in women1, an accurate and timely diagnosis is critical for effective treatment decisions and improved clinical outcomes.

Siemens Healthineers, with a comprehensive menu for simultaneous detection of up to 9 STI pathogens in a single test, provides you with a variety of testing options for your lab.2

In addition, syndromic testing for STIs can now be more easily incorporated into your routine lab operations by being performed on your existing molecular diagnostics instruments.3


Share this page:

1https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)
2Fast Track Diagnostics STI assays are CE-marked for IVD use in the EU. Product availability will vary by country. Please contact your local sales representative for availability.
3Please visit fast-trackdiagnostics.com or refer to the User Manuel for the instrument compatibility list.